News and Press Releases Search About the CF Foundation Public Policy CFTR Modulators Drug Pipeline Medications (-) Genetic Therapies 2015 2014 (-) 2012 2011 2008 2006 News (-) Press Releases About the CF Foundation | CFTR Modulators | Genetic Therapies The Cystic Fibrosis Foundation Applauds FDA Approval of Kalydeco™, First Drug to Address the Underlying Cause of Cystic Fibrosis Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model Jan. 31, 2012 | 5 min read
